What's New on the FDA Drugs Site
November 17, 2015
- Formal Meetings Between the FDA and Biosimilar Biological Product Sponsors or Applicants Guidance for Industry (PDF - 306KB)
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- FDA approves Darzalex (daratumumab) for patients with previously treated multiple myeloma
- FDA Drug Safety Communication: FDA advises of rare cases of underactive thyroid in infants given iodine-containing contrast agents for medical imaging
- FDA Drug Shortages
- Clonidine Hydrochloride and Chlorthalidone Tablets, USP (Clopres) (New - Discontinuation)
- Quinapril Hydrochloride and Hydrochlorothiazide Tablets (New - Discontinuation)
- Trace Elements (Updated - Resolved)
- National Drug Code Directory
- Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)
.png)
No hay comentarios:
Publicar un comentario